ImmunityBio & BeiGene Collaborate on Phase 3 ANKTIVA Trial
January 30, 2025
ImmunityBio, announced it has entered into a collaboration and supply agreement with BeiGene, (to be changed to BeOne Medicines, Ltd.), a global oncology company, to